Skip to main content

Table 2 The clinical factors and PET metabolic parameters analysis in the training cohort

From: Development and validation of a 18F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study

 

Univariate Cox

P-values

Multivariate Cox

P-values

HR

Age

0.439

  

Abortion

0.956

  

Menstruation status

0.449

  

Pathology

0.002

0.006

2.862 (0.911–8.987)

FIGO stage

0.014

0.405

 

MTD

0.015

0.429

 

LNM

0.010

0.452

 

EBRT total dose

0.710

  

Chemotherapy model

0.089

  

Chemotherapy cycle

0.006

0.091

 

LMR

0.785

  

NLR

0.343

  

PLR

0.993

  

MTV

0.004

0.072

 

TLG

0.043

0.321

 

SUVmax

0.906

  

SUVmean

0.846

  

SUVmin

0.327

  
  1. PFS: progress free survival; FIGO: International Federation of Gynecology and Obstetrics; MTD: the maximum tumor diameter; LNM: lymph nodes metastasis; EBRT: external beam radiotherapy; LMR: lymphocyte to monocyte ratio; NLR: neutrophil to lymphocyte ratio; PLR: platelet to lymphocyte ratio; MTV: metabolic tumor volume; TLG: total lesion glycolysis; SUVmax: maximum standardized uptake value; SUVmean: mean standard uptake value; SUVmin: minimum standardized uptake value
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us